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Gold nanostructures have proven to be a versatile platform for a broad range of biomedical
applications, with potential use in numerous areas including: diagnostics and sensing, in vitro and
in vivo imaging, and therapeutic techniques. These applications are possible because of the highly
favorable properties of gold nanostructures, many of which can be tailored for speciﬁc
applications. In the ﬁrst part of this tutorial review, we will discuss the most critical properties of
gold nanostructures for biomedical applications: surface chemistry, localized surface plasmon
resonance (LSPR), and morphology. In the second part of the review, we will discuss how these
properties can be harnessed for a selection of biomedical applications, aiming to give the reader
an overview of general strategies as well as highlight some recent advances in this ﬁeld.
Introduction
While gold has many favorable properties as a bulk metal
(such as high electrical conductivity, reﬂectivity, malleability,
and resistance to corrosion and oxidation), new properties and
potential applications emerge when it is ﬁnely divided into the
nanoscale. One of the most dramatic and useful changes is in
gold’s interaction with light. When a gold nanoparticle is
irradiated with light, strong absorption and/or scattering will
occur at speciﬁc resonant wavelengths, which depend greatly
on the morphology and dielectric environment of the gold
nanoparticle.1 This phenomenon is known as localized surface
plasmon resonance (LSPR), and is the origin of many of the
new applications of nanoscale gold particles. This pheno-
menon has been used for hundreds of years to give a rich
red color to stained glass, but systematic study only began in
1857 when Michael Faraday demonstrated the synthesis of
gold colloids in an aqueous medium.2 The next major
advances came when Gustav Mie solved Maxwell’s equations
for spherical particles, making it possible to predict and
explain the optical properties of gold nanospheres, and in
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1951 when John Turkevich pioneered a robust and simple
synthesis method.3,4 Both Mie theory and the Turkevich
synthesis are still widely used today. Building on these
foundational studies, a resurgence of interest in gold nano-
structures has occurred in recent years. With more powerful
characterization tools and more reﬁned synthetic methodo-
logies, scientists have been able to achieve unprecedented
control over the dimensions, morphology, and properties of
gold nanostructures.5–7
Along with this greater degree of control, a wide variety of
new applications for gold nanostructures have been realized,
particularly in the area of biomedicine.8–12 By tuning the
LSPR from the visible into the near infrared (NIR) region, it
is possible to harness the strong optical properties of gold
nanostructures in biological environments, as absorption from
water and hemoglobin is low at these wavelengths.13,14
Combined with the other favorable properties of gold nano-
structures, including relatively bio-inert surfaces, easily
modiﬁed surface chemistry, and a high degree of size and
shape control, this has made gold nanostructures a strong
platform for a broad spectrum of biomedical applications.5–12
In this tutorial review, we will ﬁrst give an overview of the
properties of gold nanostructures most critical to biomedical
applications: controllable surface chemistry, LSPR, and
morphology. In the following sections, we will explain how
these properties can be exploited to create and improve
biomedical diagnostic techniques and treatments, including
discussions of cellular uptake, optical imaging techniques,
drug delivery, and photothermal treatment.
Properties of gold nanostructures
Controllable surface chemistry
A number of the critical attributes that make gold nano-
structures such a promising platform for biomedical
applications are related to the surface chemistry of gold. First
of all, the non-reactive and relatively bio-inert nature of gold
makes this metal a good candidate for both in vitro and in vivo
applications.15 The low cytotoxicity of gold nanostructures
has been demonstrated in a number of studies, and initial
in vivo and clinical biocompatibility studies have also shown
favorable results.15–17 Gold colloids were studied in humans in
the 1950’s as radiotracers for sentinel lymph node biopsy, and
a phase I clinical trial has recently been completed for gold
nanosphere-based drug carriers.16–18 Despite the involvement
of high doses of a toxic agent (tumor necrosis factor-alpha,
TNF), minimal side eﬀects were observed from treatment with
gold nanospheres.17 Nevertheless, it is important that we
continue to study the biocompatibility of these materials, as
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their suitability for diﬀerent applications will depend heavily on a
number of factors, including the size and shape of the particles,
the surface coatings, and the method of administration.11,15
Though non-reactive in most situations, the surface of gold
is well-known for forming strong, stable gold–thiolate bonds
(Au–S, B50 kcal/mol) to molecules with thiol (–SH) or
disulﬁde groups (S–S).19 This binding has been extensively
studied with self-assembled monolayers (SAMs), where mole-
cules (typically long-chain alkanethiols) generate highly
ordered monolayers when they adsorb onto a gold surface.19
This well-characterized binding has been used extensively to
add functionality to gold surfaces and gold nanostructures
(Fig. 1A).20–22 By carefully choosing the functional group at
the distal end of the molecule, it is possible to design and
generate a well-deﬁned interface to interact (or not interact)
with cells and biomolecules in speciﬁc ways. Gold nano-
structures can also adsorb biological molecules in a non-
speciﬁc manner. This binding can be used to add speciﬁc
functionality, but is also an important factor to consider when
examining the cell/gold interaction in a biological environ-
ment, as a variety of proteins will adsorb to a non-protected
gold surface when it is transferred into a biological medium.
The adsorbed proteins can aﬀect the surface properties of gold
nanostructures and thus their cellular uptake properties.22
For in vivo applications, most gold nanostructures are
conjugated with poly(ethylene glycol) (PEG). PEG is a
biocompatible polymer that helps prevent particle aggregation,
non-speciﬁc protein adsorption, and the uptake of circulating
gold nanostructures by the reticuloendothelial system (RES),
allowing for longer circulation in the bloodstream and
consequently greater accumulation of gold nanostructures in
tumors through passive targeting.23 Passive targeting is a
simple and eﬀective means to concentrate nanostructures in
tumors for cancer therapy or imaging. Due to the rapid
growth of blood vessels in tumors, the blood vessel walls are
typically more porous and leaky than those found in healthy
tissue. For this reason, it is easier for appropriately sized
nanostructures to move from the bloodstream into tumors.23
Additionally, the lymphatic drainage from tumors is reduced
compared to healthy tissue, making it harder for nano-
structures to leave the tumor once they are there. Combined
together, these eﬀects are referred to as passive targeting or the
enhanced permeability and retention (EPR) eﬀect.
When the surfactants, capping agents, or stabilizers used for
nanoparticle synthesis bind less strongly compared with
gold–thiolate interactions, their replacement with a thiol-
terminated PEG is relatively straightforward, requiring simple
incubation of gold nanostructures with an excess amount of
PEG for a few hours.24 Alternatively, a layer of PEG
(or another polymer) can be conjugated in an additional layer
on top of the surface of the as-synthesized particles.25
It is also possible to create gold nanostructures with active
targeting capabilities via careful surface modiﬁcation.23,24
Active targeting takes advantage of the fact that rapidly
growing cancer cells over-express certain receptors on their
surface. If nanostructures are conjugated with a compli-
mentary moiety (e.g., antibodies, peptides, and folate, among
others), then they will bind to cancer cells as they circulate,
increasing their concentration in the desired region. The
binding of the targeting moiety can either occur directly to
the surface of the nanostructure, to the terminal end of an
attached PEG chain with an appropriate tail group (e.g., a
carboxylic acid-based group to bind to amine groups found in
antibodies), or through click chemistry.25
Thiolate binding and polymer adsorption can also be
employed to attach a number of other functional groups to
the surface of gold nanostructures.17,20,21 For example, it is
possible to control the charge of a gold nanostructure by
adsorbing speciﬁc polymers to the surface, which is important
as surface charges can have a signiﬁcant eﬀect on both the
cellular uptake and biodistribution of nanostructures.
Positively charged nanostructures have been shown to have
enhanced aﬃnity to negatively charged cell surfaces and are
the most likely to cross cellular membranes and enter the
cytoplasm of cells, an important aspect to consider in delivery
applications.22,26 It is also possible to use the thiol group to
attach oligonucleotides for sensing applications, smart
polymers or drugs for stealth delivery, as well as a wide variety
of other types of molecules.17,20,21 A few examples of diﬀerent
functional groups that can be attached will be discussed in the
application section below.
Localized surface plasmon resonance
One of the most interesting and powerful properties of gold
nanostructures is localized surface plasmon resonance (LSPR).
Fig. 1 (A) Gold nanostructures can be conjugated with a wide variety
of functional moieties, both through the gold–thiolate bond and by
passive adsorption. (B) Localized surface plasmon resonance (LSPR)
is another critical property of gold nanostructures that results from the
collective oscillation of delocalized electrons in response to an external
electric ﬁeld.
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When a gold nanostructure encounters electromagnetic
radiation of an appropriate wavelength, the delocalized
conduction electrons of the metal will begin to oscillate
collectively relative to the lattice of positive nuclei with the
frequency of the incoming light. Fig. 1B illustrates this
phenomenon for a gold nanosphere. This process can be
divided into two types of interactions: scattering, in which
the incoming light is re-radiated at the same wavelength in all
directions, and absorption, in which the energy is transferred
into vibrations of the lattice (i.e., phonons), typically observed
as heat. Together, these processes are referred to as extinction
(extinction = absorption + scattering). In addition, LSPR
also generates strong electric near ﬁelds close to the surface of
the particle. All three of these interactions can be harnessed for
biomedical applications, which will be discussed in greater
detail in the second half of this review.
The speciﬁcs of the LSPR response of gold nanostructures
depend on a number of variables, particularly the size, shape,
and morphology of the nanostructure, as well as the dielectric
environment.1,27,28 Consequently, controlling the morphology
of gold nanostructures is a powerful route to control the LSPR
response. Even small changes in aspect ratio or corner sharp-
ness can have a large impact.27 For biomedical applications,
scientists are typically most interested in gold nanostructures
that absorb and scatter strongly in the near-infrared region
(NIR, 650–900 nm), as light can penetrate deeply into tissue in
this region due to low absorption from blood and water, and
scattering from tissue.13 A typical gold nanosphere has a
LSPR wavelength around 520 nm. By changing the size it is
possible to shift this peak slightly, but to achieve strong
extinction in the NIR region it is necessary to synthesize new
morphologies with more tunable plasmonic properties.14 Two
general strategies are used to shift the LSPR ratio into the
NIR region: careful control of the aspect ratio for solid
structures or ﬁne-tuning of the wall thickness of hollow or
core–shell structures.14,29–31
Morphological eﬀects
Commonly used morphologies. Fig. 2 shows transmission
electron microscopy (TEM) images of both gold nanospheres
and three types of gold nanostructures that have been
engineered to have a strong LSPR in the NIR region: gold
nanorods, gold nanoshells, and gold nanocages. These four
morphologies represent the most commonly used gold nano-
structures for biomedical applications.
Gold nanospheres are the simplest structure to synthesize,
and there are now well-developed techniques to produce
particles of high uniformity with a variety of sizes.20 In a
typical reaction, a dissolved gold salt (such as HAuCl4) is
reduced to gold atoms in the presence of a capping agent or
surfactant to prevent aggregation. In the most commonly used
method, the reducing agent and capping agent are the same:
citrate ions. Depending on the size of the nanosphere, strong
LSPR extinction will occur between 500–600 nm. Detailed
tuning of spectra and theoretical analysis of the size
dependence of LSPR peaks are available for gold nanospheres
and all the nanostructures discussed herein in a review by our
group in a previous issue of this journal.14
Gold nanorods typically have two LSPR peaks, one for the
transverse mode around 515 nm and the other for the longi-
tudinal mode whose position depends strongly on the aspect
ratio of the rod. These structures are typically synthesized by a
seed-mediated, solution-phase method, where small gold seeds
are added to a series of growth solutions.30 By adjusting the
synthesis parameters (e.g., the concentrations of key reagents
and the size of the initial gold seeds), it is possible to synthesize
nanorods with strong LSPR-based absorption across the
visible spectrum and into the NIR.
The LSPR of gold nanoshells and gold nanocages can also
be tuned into the NIR by adjusting the thickness of gold walls
surrounding a dielectric or hollow core. However, diﬀerent
synthetic methods are used to achieve this tuning in each type
of structure. Nanoshells are created by depositing small gold
nanoparticles onto the surface of a silica sphere, followed by
deposition of more gold through chemical reduction.31 The
ﬁnal LSPR depends on the ratio between the diameter of the
particle (typically B120 nm), and the thickness (B10 nm) of
the deposited gold layer.
Gold nanocages are created by hollowing out the interior of
a sacriﬁcial template of silver nanocubes (as well as silver
nanocrystals with other shapes). When silver nanocubes are
titrated with a gold salt (typically HAuCl4), a galvanic
replacement reaction occurs, causing gold atoms to be
deposited on the surface of the nanocube and silver atoms to
be dissolved from a small pit in the surface.32 This pit
gradually expands, hollowing out the interior until a uniform
shell of gold–silver alloy is formed. If more HAuCl4 is titrated
at this point, silver will be selectively removed from the alloy,
and the resulting vacancies in the lattice will coalesce into
pores on the surface of the nanocages. These pores will form
Fig. 2 Commonly studied gold nanostructures: (A) multiply twinned
gold nanoparticles (often referred to as nanospheres), (B) gold nano-
shells (silica beads coated with a polycrystalline gold layer), (C) gold
nanorods, and (D) gold nanocages. The scale bar in the inset is
200 nm. Modiﬁed with permission from ref. 53 (A, B) and ref. 63
(C), copyright 2010 Wiley and 2007 American Chemical Society,
respectively.
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preferentially on the corners if nanocubes with truncated
corners are used, allowing for precise control over their sizes,
positions, and uniformity.33 The hollow porous structure of
nanocages enables additional applications, due to their ability
to deliver drugs and other eﬀectors stored in the interior of the
cages.21 Gold nanocages can be created with a wide variety of
sizes (i.e. 30 to 150 nm or more) by changing the size of the
initial silver nanocubes.
Beyond LSPR tuning, the speciﬁc morphology of gold
nanostructures can also have a signiﬁcant impact on the
cellular uptake, in vivo distribution, and pharmacokinetics,
key attributes to control for biological applications.24,34–36 For
example, the size of nanostructures will aﬀect both the amount
of time they circulate in the blood, where they accumulate, and
whether they can be easily cleared from the body. Initial
experimental and theoretical studies with gold nanospheres
have suggested that B50 nm is the ideal size for cellular
uptake in an in vitro environment, though the optimum
particle size will also depend on the type of surface coating
employed (as this has a strong eﬀect on the eﬀective size in an
aqueous medium), and the optimum size for in vivo experi-
ments may also be diﬀerent from those determined from
in vitro studies.24,34–36
Eﬀect of morphology on scattering and absorption cross
sections. In addition to the peak position, the size and shape
of gold nanostructures will determine the relative magnitudes
of absorption and scattering that occur.14,28,37,38 These inter-
actions are quantiﬁed by optical cross sections, which
normalize the amount of absorption and/or scattering by the
physical cross section of the nanostructure. The overall
extinction cross section (se) can be divided into its two
components, the absorption and the scattering cross sections
(sa and ss, respectively). The relative magnitude of sa and ss
will vary depending on the size and geometry of the nano-
structure, making morphological control useful in optimizing
the optical properties for applications that rely more heavily
on one of the two components. For example, gold nano-
structures with relatively large ss are ideal for enhancing the
contrast of optical coherence tomography (OCT), while
photoacoustic tomography (PAT) imaging requires contrast
agents with large sa.
8–11,39
Typically, the relative contributions of these cross sections
are calculated theoretically using either Mie theory or the
discrete-dipole approximation (DDA).3,40 Mie theory provides
an exact solution by directly solving Maxwell’s equations, but
is limited to spheres, spheroids, shells, and inﬁnite cylinders.
The DDA method can be used for any structure, as it
approximates a nanostructure as an array of polarizable
points, which interact with both incoming light and each
other. While both are useful techniques to model the expected
properties, it is more desirable to have an experimental
method to directly measure these contributions. For this
reason, a technique has been developed that combines
UV-Vis spectroscopy and photoacoustic imaging to experi-
mentally determine sa.
41 This technique has been used to
compare the contributions of sa and ss to the optical
properties of most of the gold nanostructures shown in
Fig. 2. The general technique is as follows: se is obtained using
a UV-vis-NIR spectrometer, together with the well-known
Beer–Lambert law while photoacoustic imaging is used to
measure sa, and then the ratio between the two is calculated.
41
Photoacoustic imaging is based on the photoacoustic eﬀect,
where absorption of pulsed laser radiation results in transient
heat. The resulting thermo-elastic expansion generates an
acoustic signal, which can be directly measured. As the
photoacoustic signal is generated due to the optical absorption
of a material, the signal is expected to be directly proportional
to the absorption coeﬃcient (ma).
42,43 The relationship between
the photoacoustic signal and ma can be calibrated using an
organic dye, making it possible to determine sa for diﬀerent
nanostructures by dividing the photoacoustically measured ma
by the concentration of particles.
Fig. 3A shows a setup of the photoacoustic imaging system
used for these optical measurements.41 The light travels
through an optical condenser and is focused on tubes
embedded in an optically scattering medium and ﬁlled with
aqueous suspensions of gold nanostructures. The photo-
acoustic signals are detected by an ultrasound scanning
transducer placed inside the optical condenser. Fig. 3B shows
a typical photoacoustic image of gold nanocages at diﬀerent
Fig. 3 (A) An experimental setup of a photoacoustic (PA) imaging
system. (B) A typical depth-resolved B-scan PA image (x–z scan)
of a gold nanocage suspension at three diﬀerent concentrations.
Reproduced with permission from ref. 41, copyright 2009 American
Chemical Society.
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concentrations, showing the proportional relationship
between the concentration of particles and the photoacoustic
signal.
Table 1 shows the optical cross sections of diﬀerent types of
gold nanostructures obtained with both photoacoustic and
theoretical methods. For gold nanospheres, calculations were
performed with Mie theory, while calculations for gold
nanocages and nanorods were carried out using the DDA
method.3,40 Each type of nanostructure has its own character-
istic sa/se ratio, which is essentially the same as that predicted
by calculation. Some themes emerge from this data (and other
studies) that are useful to keep in mind when designing gold
nanostructures for biomedical applications. In general, optical
cross sections increase as the dimensions of a nanostructure
increase. On the other hand, as the size increases, the ratio of
sa to se decreases.
9,41 Consequently, to create gold nano-
structures with the highest absorption cross section it is
necessary to ﬁnd a balance between these two eﬀects.
Biomedical applications of gold nanostructures
The interesting properties described above have led to strong
interest in the use of gold nanostructures for a variety of
biomedical applications. Gold nanostructures have been used
for fundamental studies of how nanomaterials behave in both
in vitro and in vivo environments, have enabled or enhanced a
number of diagnostic techniques, and show great potential in
targeted therapeutics.8–12,44 Table 2 summarizes the connec-
tions between the properties listed in the ﬁrst section of this
review and some of the most extensively explored applications.
Straightforward surface modiﬁcation plays an important
role in many applications. The ability to optimize the uptake
of nanostructures and direct them to particular locations in the
body through passive and active targeting is particularly
advantageous, as many current treatments for diseases such
as cancer aﬀect the body broadly, leading to harsh side eﬀects
that could hopefully be eliminated with more focused treat-
ments. In addition to having a strong eﬀect on the bio-
distribution and targeting of gold nanostructures, the gold–thiolate
bond makes it possible to add new functionality to gold
nanostructures. For example, thermosensitive polymers bound
to the surface can allow gold nanostructures to serve as drug
delivery vehicles that release their payload in response to
temperature.21,45 Conjugation with pH sensitive molecules
can also transform gold nanostructures into all-optical pH
sensors, and may be a route to selectively deliver drugs to the
interior of cells.46 It is also possible to conjugate certain
therapeutics directly to the surface of the nanostructures, using
the stealth-like properties of PEG coatings to transport highly
toxic drugs to the tumor site while minimizing side eﬀects.16,17
The strong optical response of gold nanostructures due
to LSPR is also critical to many of their biomedical
applications.14 The diﬀerent optical responses that result from
this phenomenon and the corresponding applications are
shown in Scheme 1. Light scattering is used primarily in
imaging techniques such as optical coherence tomography
(OCT) where the presence of particles with large scattering
cross sections enhances image contrast, and dark-ﬁeld micro-
scopy, where transmitted light is blocked and scattered light is
collected, showing scattering particles with a bright color
against a dark background.8–11 Absorption is used in a variety
of techniques that take advantage of the fact that strongly
absorbing gold nanostructures can become highly localized
heat sources when irradiated with a laser through the photo-
thermal eﬀect. The generated heat can be used to initiate
release in drug delivery systems, enhance contrast in optical
imaging techniques like photoacoustic imaging, and provide
photothermal treatment.8–11,21,39,45,47,48 A selection of these
techniques will be described in greater detail below.
Table 1 Comparison of the optical cross-sections of gold-based nanostructures obtained experimentally by photoacoustic imaging and theoretical
calculations, respectively.a Reproduced with permission from ref. 41, copyright 2009 American Chemical Society
Cross-section (1015 m2)
sa/seExtinction (se) Absorption (sa)
Nanocages (45.0 nm) Experimental 7.26  0.06 5.96  0.25 0.82  0.04
Calculated 19.88 16.26 0.82
Nanocages (32.0 nm) Experimental 2.99  0.04 3.05  0.12 1  0.04
Calculated 6.39 6.02 0.94
Nanorods (44.0  19.8 nm) Experimental 2.16  0.02 1.87  0.23 0.87  0.11
Calculated 2.15 1.83 0.85
Nanospheres (150 nm) Experimental 145  14.76 —b —
Calculated 99.96 5.73 0.056
a All the values were obtained at 638 nm. b Not detected with photoacoustic imaging.
Table 2 The critical properties of gold nanostructures used in common applications
Diagnostic sensing In vitro imaging In vivo imaging Drug delivery Controlled release Photothermal treatment
Biocompatibility | | | | | |
Surface modiﬁcation | | | | | |
Scattering | | |
Absorption | | | | | |
Near-ﬁelds |
Photoluminescence | |
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The LSPR of gold nanostructures has also enabled a
number of diﬀerent sensing techniques, which we will only
discuss brieﬂy as they have been covered extensively by
previous reviews in this journal.49 The strong local ﬁelds from
LSPR can enhance the Raman signals of molecules near the
surface of a metallic nanostructure by many orders of
magnitude. This technique is known as surface-enhanced
Raman spectroscopy (SERS), and can enable ultrasensitive
detection of biomarkers. Interested readers are directed to
ref. 50 and 51 for more information about this technique. The
sensitivity of LSPR to changes in dielectric environment and
aggregation has also been harnessed to fabricate colorimetric
sensors.20,52 A classic example is detection of a target DNA
strand by conjugating gold nanospheres with the compli-
mentary oligonucleotide. When the target strand is present,
the gold nanospheres will aggregate, resulting in a dramatic
color change from red to blue due to coupling between the
plasmons of the individual particles.52
In this review, we will focus on three general areas. First, we
will discuss the cellular uptake of gold nanostructures,
including some recent studies of mixtures of particles.
Secondly, we will discuss how gold nanostructures can be used
for imaging and diagnostics in both in vitro and in vivo settings.
Finally, we will discuss some potential therapies based on gold
nanostructures: stealth delivery of a toxic drug through gold
nanostructure conjugation, controlled release of eﬀectors from
gold nanocages, and photothermal therapy, where heat from
LSPR absorption is used to directly destroy cancer cells.
Cellular uptake studies
Gold nanostructures are an ideal system to study cellular
uptake of nanomaterials for a number of reasons: it is possible
to synthesize a wide variety of particle morphologies with
similar sizes, the eﬀect of diﬀerent surface modiﬁcations/
targeting mechanisms can be studied due to strong gold–
thiolate bonds, and the total amount of gold taken up by cells
can be determined with high accuracy and sensitivity by
inductively-coupled plasma mass spectrometry (ICP-MS).14,24
Initial studies with gold nanospheres have shown that 50 nm is
an ideal size for cellular uptake, ﬁtting with theoretical
predictions.35,36 However, the presence of PEG layers and
other changes in surface chemistry will also have a
considerable eﬀect on uptake results.22,24 In particular,
positive charges and targeting ligands can signiﬁcantly
increase cellular uptake.
Although ICP-MS provides accurate quantitative data for
the cellular uptake of a single type of particle, it cannot
diﬀerentiate diﬀerent types of gold nanostructures in a
mixture, making it impossible to study interference or compe-
titive uptake using this method. Recently, a technique has been
developed that instead relies on the diﬀerent LSPR properties
of gold nanostructures to determine cellular uptake.53
Gold nanospheres and nanorods with similar diameters but
diﬀerent aspect ratios were incubated independently and then
co-incubated with human breast cancer SK-BR-3 cells
(Fig. 4A). Three surface coatings were studied for each
nanostructure: unmodiﬁed (with citrate or CTAB left from
synthesis), PEGylated, or antibody-conjugated (anti-HER2-PEG).
Fig. 4B illustrates how this spectroscopic method can
determine the concentration of gold nanospheres and nano-
rods from a mixture. Gold nanorods have two LSPR peaks, a
transverse peak at B515 nm, and a longitudinal peak that
depends strongly on the length of the rod (652 nm for this
example). While the peak at 515 nm overlaps with the peak of
the nanospheres at 520 nm, the concentration of gold nano-
rods can be determined through a calibration curve at 652 nm.
The relative contribution of nanorods to the peak at
515–520 nm can then be subtracted before calculating the
concentration of nanospheres.
Fig. 4C shows the cellular uptake of nanospheres and
nanorods when they were mixed and then incubated with the
cells. For comparison, the uptake of gold nanospheres and
nanorods when they were independently incubated with the
cells is shown in Fig. 4D. These ﬁgures indicate, in some cases,
that the uptake of gold nanospheres was signiﬁcantly reduced
when co-incubated with gold nanorods, as compared with the
independent incubation. No clear trends were found relating
the shape of gold nanostructures to their uptake, implying that
surface chemistry is likely a more important factor aﬀecting
the uptake of gold nanostructures.22
Two-photon microscopy
Optical imaging methods are currently some of the most
powerful tools available for in vitro studies, and a number of
optical techniques are also being investigated as low cost,
portable, non-ionizing alternatives to current in vivo techni-
ques like computed tomography (CT) and magnetic resonance
imaging (MRI).42,43 One powerful optical technique is
two-photon microscopy that has gained popularity due to its
ability to penetrate deeper into tissue than comparable high
resolution imaging techniques like confocal microscopy.
Typical depth penetration is on the order of 100’s of microns.
While originally used to image NIR ﬂuorescence dyes, it has
been recently demonstrated as a method to image gold nano-
structures in cultured cells, tissue phantoms, and in vivo
circulation for blood vessels near the skin surface, such as
those in a mouse ear.54,55 The resulting signal has been
reported to be 60–140 times greater than seen with conven-
tional organic dyes.55 When gold nanostructures are excited
with a femto-second pulsed laser, the absorption of two
Scheme 1 Localized surface plasmon resonance (LSPR) is the origin
of a number of interesting phenomena observed with gold nano-
structures. These properties have enabled a number of applications,
which are indicated in bold.
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photons excites electrons from the d-band to the sp-band,
creating electron-hole pairs. When these electron-hole pairs
recombine, luminescence is emitted in the visible region. This
process is signiﬁcantly enhanced when the LSPR of the
nanostructure is in the NIR region, where it matches well
with the wavelength of the photons used to excite the
luminescence. When compared with ﬂuorescent dyes, this
technique is not as susceptible to photobleaching, a signiﬁcant
advantage.
Two-photon microscopy was used to demonstrate the
in vitro targeting abilities of antibody-conjugated gold nano-
cages.24 Fig. 5 shows the results after anti-EGFR conjugated
Fig. 5 (A–C) U87MGwtEGFR cells after incubation with gold nanocages functionalized with EGFR antibodies. (D–F) Cells after incubation
with non-targeted gold nanocages (functionalized with mPEG). (A, D) Two-photon images of gold nanocages showing little uptake without
targeting. (B, E) Fluorescence images of SK-BR-3 cells with FM4-64 dye used to stain the membranes and endosomes. (C, F) Overlay of images of
nanocages and images of cells, showing clear overlap between the two for the targeted nanocages. Modiﬁed with permission from ref. 24, copyright
2010 American Chemical Society.
Fig. 4 Cellular uptake of gold nanostructures. (A) Schematic of cellular uptake of gold nanostructures. (B) Detection method to distinguish
between uptake of nanospheres and nanorods. (C) Cellular uptake of nanospheres and nanorods by SK-BR-3 cells when the gold nanospheres and
nanorods were mixed (60 pM each) and then incubated with the cells at 37 1C for 24 h. (D) Cellular uptake of nanospheres and nanorods by
SK-BR-3 cells when the gold nanostructures (60 pM) were incubated independently at 37 1C for 24 h.N is the number of gold nanostructures taken
up per cell. Modiﬁed with permission from ref. 53, copyright 2010 Wiley.
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nanocages (A–C) and PEGylated nanocages (D–F) were
incubated with U87MGwtEGFR cells for 3 h. The ﬁrst
column shows two-photon luminescence from gold nanocages,
the second column shows standard ﬂuorescence imaging of cell
membranes and endosomes with FM4-64 dye, and the third
column shows an overlay of the two. It is clear from these
images that the gold nanocages with anti-EGFR signiﬁcantly
increased the cellular binding and uptake.
Photoacoustic imaging
Photoacoustic imaging can oﬀer non-invasive optical imaging
at even greater depths than two-photon microscopy.39,42,43
Both the spatial resolution and the imaging depth depend on
the ultrasonic detection frequency, which can be adjusted
depending on the desired application. The spatial resolution
can be varied from 5 to 150 mm and the imaging depth can be
varied from 0.7 to 30 mm.42 When tissue is irradiated with a
pulsed laser source, the resulting heat creates an acoustic
signal that can be measured and converted into an image by
a scanning transducer. This signal can be enhanced by the use
of contrast agents that strongly absorb light, such as gold
nanostructures.42 Fig. 6 shows the depth capability of photo-
acoustic imaging when gold nanocages were used as a contrast
agent for in vivo sentinel lymph node detection (one of the ﬁrst
steps in breast cancer staging).39 In each successive panel, an
additional layer of chicken breast tissue was placed on top of
the region being imaged to demonstrate the feasibility of using
this method to detect sentinel lymph nodes for breast cancer
staging in humans. A distinct image of the sentinel lymph node
could be obtained as deep as 33 mm, though this limitation
was actually imposed by the memory of the acquisition system.
This depth is signiﬁcantly greater than the B12 mm depth of
sentinel lymph nodes in humans, making this a promising way
to detect sentinel lymph nodes without the invasive procedures
that are currently necessary.
Drug delivery
Drug delivery is a prime example of how gold nanostructures
can be used for therapy in addition to diagnostics.17,20,21,56
Most work in this area has centered on cancer treatment, as
targeted therapies are greatly needed in this ﬁeld due to the
harsh side eﬀects of current broad-based treatments. Through
both passive and active targeting, the concentration of drug
can be increased at the tumor site while limiting the exposure
of (and consequent toxicity to) healthy tissue.23 Stage I clinical
trials have been completed for the delivery of tumor necrosis
factor (TNF) bound to the surface of gold nanospheres.17
TNF is a potent cytokine that has shown antitumor properties
in isolation and even greater eﬀects as part of a combined
therapy.57,58 Though the mechanism for action is complex,
results suggest that TNF is able to signiﬁcantly increase the
permeability of the tumor vasculature, eventually causing
destruction of the vascular lining, and also allowing for greater
delivery of other chemotherapeutic agents.57,58 Unfortunately,
the practical dosage is limited by the severe toxicity of TNF.
However, when TNF is conjugated to gold nanospheres, the
toxicity can be greatly reduced, allowing for signiﬁcantly
higher dosages of TNF to be delivered to the tumor site.16
Fig. 7 shows some of the results from in vivo mouse studies
of TNF delivery and the resulting toxicity.16 In these studies,
B30 nm gold nanospheres were conjugated with a combina-
tion of TNF and PEG. TNF is thought to function as an active
targeting ligand in addition to being the therapeutic payload.
Fig. 7A shows the concentration of TNF in the tumor after
treatment with either native TNF (i.e. free in solution) or gold
nanospheres conjugated with both PEG and TNF (Au-TNF).
The presence of PEG was found to be critical to long
circulation times and increased accumulation of TNF in
tumors, as unprotected particles were rapidly cleared by
Fig. 6 Depth capability of sentinel lymph node (SLN) mapping with
gold nanocages for non-invasive in vivo breast cancer staging. Photo-
acoustic images taken (A) before and (B–E) after the injection:
(A) control image; (B) 28 min; (C) 126 min with a layer of chicken
breast tissue placed on auxillary region, total imaging depth was 10 mm;
(D) 165 min with the second layer of chicken breast tissue, total
imaging depth was 21 mm; (E) 226 min with the third layer of chicken
breast tissue, total imaging depth was 33 mm. (F) Photoacoustic
B-scan with 20 times signal averaging, showing the SLN located
33 mm deep. Memory of the acquisition system limited the record
length in depth. (G) The amplitude variations of photoacoustic signals
over imaging depths. Data were scaled down to 0 dB and normalized by
the maximum. Error bar represents standard deviation. (F) Color bars
represent the optical absorption. BV, blood vessel. Reproduced with
permission from ref. 39, copyright 2009 American Chemical Society.
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RES. While the concentration of native TNF inside the tumor
was relatively constant, the concentration of Au-TNF
continued to increase and was over 6-fold higher than the
native TNF after 3 h. Mice treated with Au-TNF also had
smaller tumor volumes (when comparing the same TNF
dosage) while suﬀering much lower rates of toxicity after
16 days (Fig. 7B). While 30–50% of the mice injected with
15 mg of native TNF suﬀered severe toxicity and died within
24 h of treatment, 100% of the mice treated with equal
amounts of Au-TNF survived. Interestingly, though the
unprotected particles (no PEG) could still be seen in the liver
after a month due to a size larger than the renal clearance
Fig. 7 (A) Intratumor TNF accumulation following an intravenous injection of TNF either free in solution (native) or conjugated to PEGylated
gold nanoparticles (Au-TNF) (* indicates po 0.05 versus native). (B) Antitumor eﬃcacy of native TNF and Au-TNF (Au-TNF). Percentages are
mouse survival rates (* or y indicates p o 0.05 versus untreated controls). Modiﬁed with permission from ref. 16, copyright 2004 Taylor and
Francis Inc.
Fig. 8 (A) Schematic illustrating the release mechanism for gold nanocages coated with smart polymer chains. (B) Atom transfer radical
polymerization of NIPAAm and AAm monomers as initiated by a disulﬁde initiator and in the presence of a Cu(I) catalyst. (C–D) Controlled
release from the gold nanocages covered by a smart polymer with an LCST at 39 1C (pNIPAAm-co-pAAm). (C, D) Absorption spectra of alizarin-
PEG released from the copolymer-covered Au nanocages (C) by exposure to a pulsed NIR laser at a power density of 10 mW cm2 for 1, 2, 4, 8 and
16 min and (D) by exposure to the NIR laser for 2 min at 10, 25 and 40 mW cm2. The insets show the concentrations of alizarin-PEG released
from the nanocages under diﬀerent conditions. Modiﬁed with permission from ref. 21, copyright 2009 Nature Publishing Group.
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limit, there were no signs of distress. The initial results from
stage I clinical trials using these drug-conjugated particles also
showed minimal side eﬀects in humans, and stage II trials are
being planned.17
Controlled release from gold nanocages
By using smart polymers, it is possible to create drug delivery
systems that not only deliver their payload to a speciﬁc place,
but deliver it in response to outside stimulus.21,45 Fig. 8A
shows a schematic of a drug delivery system that combines the
photothermal properties of gold nanocages with thermo-
sensitive polymers.21 The strong binding between gold and
thiol groups makes it straightforward to attach poly-
(N-isopropylacrylamide) (pNIPAAm) to the surface of the
gold nanocages by using a disulﬁde initiator (Fig. 8B). When
the gold nanocages are irradiated with a laser, the strongly
absorbed light is converted into heat through the photo-
thermal eﬀect. When the temperature rises above a certain
threshold (the low critical solution temperature, LCST), the
pNIPAAm coating undergoes a conformational change. When
the polymer is collapsed, the pores of the nanocage are
exposed, allowing for eﬀectors pre-loaded in the interior to
be released (though some release will also occur from eﬀectors
trapped in the polymer layer). The loading process is simply
the reverse—pNIPAAM-coated gold nanocages are mixed
with a solution of eﬀector at a temperature above the LCST,
then quickly cooled below the LCST to trap the contents
inside. Conveniently, the LCST of pNIPAAM can be tuned
from 32–50 1C through the incorporation of diﬀerent amounts
of acrylic acid (AAm) during the polymerization. The studies
presented here used a temperature of 39 1C as this temperature
is above body temperature (37 1C), but below the threshold
where thermal damage can occur in biological systems (42 1C).
Fig. 8C and D, shows the release proﬁles of a PEG-
conjugated alizarin dye as the laser irradiation time and laser
power were increased, respectively.21 By adjusting these
parameters, it is possible to controllably release the loaded
eﬀectors both in solution and in vitro, as the amount of dye
release increases with both time and laser power. This system
is versatile, and has also been demonstrated to release both
chemotherapeutic drugs and enzymes, which retained B80%
of their bioactivity after the release process.
Photothermal therapy
The heat generated from photothermal eﬀect can also be used
directly for therapy due to a process known as hyperthermia.
Fig. 9 In vivo photothermal treatment with gold nanocages. (A) Photograph of a tumor-bearing mouse undergoing photothermal treatment.
PEGylated gold nanocages or saline were administrated intravenously through the tail vein as indicated by the arrow. After the nanocages had
been cleared from circulation (72 h after injection), the tumor on the right ﬂank was irradiated by a diode laser at 0.7 W/cm2 with a beam size
indicated by the dashed circle. (B–I) Thermographic images of (B–E) nanocage-injected and (F–I) saline-injected tumor-bearing mice at diﬀerent
time points: (B, E) 1 min, (C, F) 3 min, (D, G) 5 min, and (E, I) 10 min. (J) Plot of the average temperature within the tumors (dashed circle) as a
function of irradiation time. (K) Plot showing the ratios of the metabolic activity between a laser-treated tumor and a non-treated tumor on the
same mouse, measured with 18F-FDG PET/CT (SUV, standardized uptake values, * indicates Po 0.001). Modiﬁed with permission from ref. 48,
copyright Wiley 2010.
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When cells are exposed to a temperature above 42 1C
(typically for several minutes), they can be irreversibly
damaged due to protein denaturing and membrane disruption.59
This technique was originally developed using NIR dyes, but
gold nanostructures can have absorption cross sections 4–5
orders of magnitude stronger and can exhibit greater
selectivity through both passive and active targeting, making
them ideal candidates for this type of therapy.48,60–61 Most
studies have focused on the use of gold nanorods, nanoshells,
or nanocages for photothermal treatment, as the NIR light
used to excite their LSPR can penetrate deeper into tissue than
the visible light that excites gold nanospheres.13
Fig. 9A to J, shows a comparison of the temperature
increase with time when the tumor of a mouse injected with
either a suspension of nanocages (B–E) or a sham treatment of
saline solution (F–I) was irradiated with a NIR continuous
wave (CW) laser.48 The nanocages were injected via the tail
vein and allowed to accumulate in the tumor through passive
targeting for 72 h before irradiation. It is clear that in the
presence of highly absorbing nanocages the laser irradiation
resulted in a signiﬁcant increase in temperature, while almost
no change was observed for the sham treatment. To conﬁrm
that this temperature change led to tumor destruction, the
metabolism of the tumor was measured before and after
treatment with [18F] ﬂuorodeoxyglucose positron emission
tomography (18F-FDG PET).62 The metabolic activity was
normalized by comparing it with a non-treated tumor on the
same mouse. As can be seen in Fig. 9K, only the nanocage-
treated mouse experienced a large decline in tumor metabolic
activity.
Concluding remarks
The tunable surface chemistry, morphology, and optical
properties of gold nanostructures make them ideal for a
variety of biomedical applications. Great progress has been
made in this ﬁeld in recent years, and we now have a better
understanding on how we can optimize the properties of gold
nanostructures for a speciﬁc application through size/shape-
controlled synthesis, precise surface modiﬁcation, and mole-
cular targeting. In this review, we have discussed a range of the
most interesting applications, including the use of gold nano-
structures as optical imaging probes both in vitro and in vivo,
their use as drug delivery and photothermal therapeutic
agents, and how they can be used to probe the many variables
that aﬀect the cellular uptake of nanomaterials. Though strides
have been made in this direction, the greatest challenge now is
to continue to enhance our understanding of the behavior and
fate of gold nanostructures in complex in vivo environments,
and truly make these techniques clinically relevant.
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